Gamma-linolenic acid ndiyo chirongwa chemafuta asidi anofungidzirwa kupa huwandu hwehutano huripo. Inowanikwa kurwisana nekuputika, gamma-linolenic acid inowanzoswa kubva kune zvinhu zvakadai semanheru primrose mafuta , borage seed oil , uye black currant mafuta kana inoshandiswa muzvokudya zvinowedzera.
Mumumuviri, gamma-linolenic acid inoshandiswa kubudisa prostaglandin (hormone-sezvinhu zvinobatsira kudzora masimba epanyama ).
Inotsanangurwa se omega-6 fatty acid.
Zvishandiso
Mune mishonga isingashandisi, gamma-linolenic acid inoshandiswa kwehutano hwakasiyana-siyana:
- kurwara
- eczema
- kusingaperi kuneta kwechirwere
- kuora mwoyo
- high cholesterol
- kumiswa kwemwedzi
- metabolic syndrome
- psoriasis
- rheumatoid arthritis
Mukuwedzera, gamma-linolenic acid inonzi inodzivirira kenza uye chirwere chemwoyo .
Health Benefits
Kusvika ikozvino, dzakawanda zvekutsvaga nezvehutano hwekutora gamma linolenic acid zvakabatanidza kushandiswa kwemanheru primrose mafuta uye / kana mafuta e borage. Kubva manheru masikati mafuta nemafuta e borage mumwe nomumwe ane zvimwe zviduku zvezvinhu zvinozivikanwa kuti zvive nehutano (zvakadai se vitamin E), zvakakosha kuona kuti gamma-linolenic acid inogona kunge isina kunyanya kuitisa kwehutano hwehutano hwemafuta.
Heino tarisiro pane zvimwe zvitsva zvekudzidza:
1) Eczema
Manheru ekutanga mafuta anokwanisa kubatsira kubvisa kubvongodza, kubvongodza, kubwinya, uye kuzvirumbidza kunobatanidza eczema , maererano nemeta-nyanzvi yakabudiswa muNyika Pharmaceutical Biotechnology muna 2006.
Zvisinei, zvidzidzo zvakawanda pamusoro pekushandiswa kwemafuta e borage mukurapa eczema zvakawana kuti mishonga ingasave yakakosha kupfuura placebo.
2) Rheumatoid Arthritis
Mafuta e-Borage uye manheru ekutanga mafuta anoratidza kuvimbiswa mukurapa rheumatoid arthritis , maererano nekuongorora kutsvakurudza kwakabudiswa muAmerican Journal of Clinical Nutrition muna 2000.
Kunyange zvazvo yakawanda yemashoko ekubudirira kwemafuta e borage inobva kuongororwa-tube uye kutsvakurudza kwemhuka, zvidzidzo zvishomanana zvinoratidza kuti borage mafuta uye manheru primrose mafuta zvinogona kuderedza unyoro uye kuzvimba muvanhu vane rheumatoid arthritis.
3) Kuenda kumwedzi
Nepo vatsigiri vanoratidza kuti gamma linolenic acid inowanikwa mumadekwana emvura inotyisa inogona kuderedza zviratidzo zvemenoopausal (zvakadai sekupisa kunopisa, usiku hwekurwa, kuvhara kwevakadzi , nekusavhiringidzika mumanzwiro), pane zvishoma zvesayenzi pakutsigira kudai. Mukutsvakurudza kwakaongororwa kwakabudiswa muAmerican Journal of Medicine muna 2005, somuenzaniso, vatsvakurudzi vakatsvakurudza zvidzidzo makumi maviri nemashanu zvekushandiswa kwemishonga yebhodanini yekuregererwa kwezviratidzo zvine chokuita nekuenda kumwedzi uye vakaona kuti manheru ano mafuta ekutanga anoonekwa seasina kubudirira.
4) Kansa
Mukutsvakurudza kwekutanga kwekenza masero, masayendisiti akaratidza kuti gamma linolenic acid inogona kubatsira kuderedza kukura kwemakumbo uye kubatsira kuvandudza kushanda kwemamwe mishonga inopesana nekenza. Zvisinei, zvishoma zvidzidzo zvakaedza gamma linolenic acid zvinokonzerwa nekenza kuvanhu.
Caveats
Kunyange zvazvo gamma linolenic acid inowanzofungidzirwa yakachengeteka, kune zvimwe zvinonetsa kuti kushandiswa kwenguva refu kwezvimwe zvinowedzera zvine gamma linolenic acid zvinogona kudzivirira simba rekudzivirira muviri uye kuwedzera ngozi yeropa.
Mukuwedzera, mafuta e-borage angakonzera kubatwa , asi manheru masikati mafuta anokonzera kushungurudza mudumbu uye kusuruvara.
Zvimwe zviyero hazvina kuongororwa kuchengetedzwa uye nekuda kwekuti kudya kwezvokudya zvinowanzosaregererwa, zvinyorwa zvemimwe michina zvinogona kusiyana nezvakataurwa pane zvakagadziriswa. Uyewo chengetedza mupfungwa kuti kuchengetedzwa kwezvokuwedzera mumadzimai ane pamuviri, vanaamai vanoyamwisa, vana, uye avo vane mishonga yezvoutano kana vari kutora mishonga haisati yasimbiswa. Iwe unogona kuwana mazano anowanikwa pakushandisa zvidimbu zvinowanikwa pano .
Kushandisa Izvo Kuti Utano
Muvanhu vazhinji, muviri unowanzobereka yakawanda gamma-linolenic acid kuburikidza nokushandura kubva ku linoleic acid (fatty acid inowanikwa mumiti, mbeu, nyama, uye marisi).
Zvisinei, vamwe vanhu (vakadai sevarwere veshuga ) vangasaita zvakakwana gamma-linoleic acid uye vanogona kubatsirwa nokutora gamma-linolenic acid muwedzere fomu.
Pamusana pekutsvakurudza kwakanyanya, zvakakurumidza kutaurira GLA kuwedzera sekurapa chero ipi zvayo. Kana uri kufunga kuishandisa, taura nachiremba wako pakutanga nezvakakodzera uye zvingave nemigumisiro yakaipa. Ramba uchifunga kuti mushonga unofanirwa haufaniri kushandiswa sechinotsiva kutarisirwa kwese. Kuzvibata nemamiriro ezvinhu uye kudzivisa kana kunonoka kutarisirwa kwese kunogona kuva nemigumisiro yakakomba.
> Sources:
> Belch JJ, Gomo A. "Evening Primrose Mafuta uye Mafuta Anokwereka muRheumatologic Conditions." Am J Clin Nutriti. 2000 71 (1 Suppl): 352S-6S.
> Henz BM, Jablonska S, PC Kerkhof van, Stingl G, Blaszczyk M, Vandervalk PG, Veenhuizen R, Muggli R, Raederstorff D. "Dhiyabhorosi, Multicentre Kuongororwa kwehutano hweHorage Mafuta muvarwere Ane Eczema." Br J Dermatol. 1999 140 (4): 685-8.
> Menendez JA. Ropero S. Lupu R. Colomer R. "Omega-6 Polyunsaturated Fatty Acid Acid Gamma-Linolenic Acid (18: 3n-6) Inowedzera Docetaxel (Taxotere) Cytotoxicity Mumunhu Mune Machechi eCarcinoma: Ukama nePidid Peroxidation uye HER-2 / Neu Tsanangudzo . " Incology Reports. 2004; 11: 1241-1252.
> Morse NL, Clough PM. "Meta-Kuongororwa kweRandomized, Placebo-Controlled Clinical Trials yaEfamol Evening Primrose Mafuta muAtopic Eczema Ndekupi Kwatinobva Kubva Muchiedza Chenyaya Dzichawanikwa?" Curr Pharm Biotechnol. 2006 7 (6): 503-24.
> Takwale A, Tan E, Agarwal S, Barclay G, Ahmed I, Hotchkiss K, Thompson JR, Chapman T, Berth-Jones J. "Kubudirira uye Kukanganiswa kweMafuta Anokwereta Muvanhu Vakura nevana Vane Eczema Inonzi: Randomized, Blind Double, Placebo Controled, Parallel Group Trial. " BMJ. 2003 13; 327 (7428): 1385.
> Whitehouse PA, Cooper AJ, Johnson CD. "Basa reSynergistic yeGamma-Linolenic Acid uye Cytotoxic Zvinodhaka Kupera Pancreatic Cell Adenocarcinoma Lines." Pancreatology. 2003; 3: 367-373.